Transcriptomics: The key to biomarker discovery during tuberculosis?

Biomarkers in Medicine

Volumn 9, Issue 5, 2015, Pages 483-495

  Van Rensburg, Ilana C ^a   Loxton, André G ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Biomarker; Epigenetics; miRNA; MLPA; RNA Seq; Systems biology; Transcriptomic analysis

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 103B; MICRORNA 142 3P; MICRORNA 144; MICRORNA 146A; MICRORNA 21; MICRORNA 223; MICRORNA 26A; MICRORNA 29A; MICRORNA 302A; MICRORNA 365; MICRORNA 421; MICRORNA 424; MICRORNA 451; MICRORNA 486 5P; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUBERCULOSTATIC AGENT;

DNA DETERMINATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION; HUMAN; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; TUBERCULOSIS; GENETICS; METABOLISM;

ANTITUBERCULAR AGENTS; BIOMARKERS; HUMANS; TRANSCRIPTOME; TUBERCULOSIS;

EID: 84929575818     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.15.16     Document Type: Review

References (82)

1. Collins FS. The human genome project: lessons from largescale biology. Science 300(5617), 286-290 (2003).
2. Takumi RMFJR, Hsiaoa YL-L, Gullansa RVJSR. Global analysis of gene expression: methods, interpretation, and pitfalls. Exp. Nephrol. 10, 64-74 (2002).
3. Laub MT, McAdams HH, Feldblyum T, Fraser CM, Shapiro L. Global analysis of the genetic network controlling a bacterial cell cycle. Science 290(5499), 2144-2148 (2000).
4. DeRisi JL. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278(5338), 680-686 (1997).
5. Eichenberger P, Fujita M, Jensen ST et al. The program of gene transcription for a single differentiating cell type during sporulation in Bacillus subtilis. PLoS Biol. 2(10), e328 (2004).
6. Pankla R, Buddhisa S, Berry M et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10(11), R127 (2009).
7. Ramilo O, Allman W, Chung W et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109(5), 2066-2077 (2007).
8. Flanagan JM, Steward S, Hankins JS, Howard TM, Neale G, Ware RE. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia. Am. J. Hematol. 84(6), 328-334 (2009).
9. Wallis RS, Kim P, Cole S et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect. Dis. 13(4), 362-372 (2013).
10. Gengenbacher M, Kaufmann SHE. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36(3), 514-532 (2012).
11. Barry CE, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7(12), 845-55 (2009).
12. Parida SK, Kaufmann SHE. The quest for biomarkers in tuberculosis. Drug Discov. Today 15(3-4), 148-157 (2010).
13. Murphy D. Gene expression studies using microarrays: principles, problems, and prospects. Adv. Physiol. Educ. 26(4), 256-270 (2002).
14. Naiser T, Kayser J, Mai T, Michel W, Ott A. Position dependent mismatch discrimination on DNA microarrays - experiments and model. BMC Bioinformatics 9(1), 509 (2008).
15. Morin R, Bainbridge M, Fejes A et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. BioTechniques 45(1), 81-94 (2008).
16. Nagalakshmi U, Wang Z, Waern K et al. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320(5881), 1344-1349 (2008).
17. Vera JC, Wheat CW, Fescemyer HW et al. Rapid transcriptome characterization for a nonmodel organism using 454 pyrosequencing. Mol. Ecol. 17(7), 1636-1647 (2008).
18. Cloonan N, Forrest AR, Kolle G et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat. Methods 5(7), 613-619 (2008).
19. Wang C, Yang S, Sun G et al. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS ONE 6(10), e25832 (2011).
20. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 1(3), 1559-1582 (2006).
21. Capizzi E, Gruppioni E, Grigioni AD et al. Real time RTPCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. Diagn. Mol. Pathol. 17(4), 220-226 (2008).
22. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol. Lett. 28(19), 1601-1613 (2006).
23. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30(12), e57 (2002).
24. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9(8), 839-845 (2008).
25. WHO. Global Tuberculosis Report (2013). http://apps.who.int
26. He H, Bretl DJ, Penoske RM, Anderson DM, Zahrt TC. Components of the Rv0081-Rv0088 Locus, which encodes a predicted formate hydrogenlyase complex, are coregulated by Rv0081, MprA, and DosR in Mycobacterium tuberculosis. J. Bacteriol. 193(19), 5105-5118 (2011).
27. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13(11), 908-914 (1994).
28. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43(3), 717-731 (2002).
29. Abebe M, Doherty TM, Wassie L et al. Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. Eur. J. Immunol. 40(1), 291-301 (2009).
30. Wu B, Huang C, Kato-Maeda M et al. Messenger RNA expression of IL-8, FOXP3, and IL-12βdifferentiates latent tuberculosis infection from disease. J. Immunol. 178(6), 3688-3694 (2007).
31. Mihret A, Loxton AG, Bekele Y et al. Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states. BMC Infect. Dis. 14(1), 257 (2014).
32. Wassie L, Demissie A, Aseffa A et al. Ex vivo cytokine mRNA levels correlate with changing clinical status of Ethiopian TB patients and their contacts over time. PLoS ONE 3(1), e1522 (2008).
33. Chaussabel D, Quinn C, Shen J et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29(1), 150-164 (2008).
34. Jacobsen M, Repsilber D, Kleinsteuber K et al. Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosis TB patients. Clin. Microbiol. Infect. 17(9), 1323-1331 (2011).
35. Maertzdorf J, Repsilber D, Parida SK et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12(1), 15-22 (2011).
36. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6(11), 1142-1151 (2005).
37. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173(7), 803-810 (2006).
38. Schluger NW, Rom WN. The host immune response to tuberculosis. Am. J. Respir. Crit. Care Med. 157(3), 679-691 (1998).
39. Jacobsen M, Repsilber D, Gutschmidt A et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J. Mol. Med. 85(6), 613-621 (2007).
40. Teitelbaum R, Glatman-Freedman A, Chen B et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl Acad. Sci. USA 95(26), 15688-15693 (1998).
41. Vanham G, Edmonds K, Qing L et al. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin. Exp. Immunol. 103(1), 30-34 (1996).
42. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defense. Biochem. Cell Biol. 80(1), 95-102 (2002).
43. Schaible UE, Collins HL, Priem F, Kaufmann SHE. Correction of the iron overload defect in β-2-Microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196(11), 1507.1513 (2002).
44. Sutherland JS, Loxton AG, Haks MC et al. Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin. Microbiol. Infect. 20(4), O230-O238 (2014).
45. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-γ production and CD25 expression with elevated forkhead box P3, transforming growth factor-β, and interleukin-4 mRNA levels. J. Infect. Dis. 195(6), 870-878 (2007).
46. Berry MPR, Graham CM, McNab FW et al. An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309), 973-977 (2010).
47. Cliff JM, Lee J-S, Constantinou N et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207(1), 18-29 (2013).
48. Hernandez J, Velazquez C, Valenzuela O et al. Low number of peripheral blood B lymphocytes in patients with pulmonary tuberculosis. Immunol. Invest. 39(3), 197-205 (2010).
49. Corominas M, Cardona V, Gonzalez L et al. B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection. Int. J. Tuberc. Lung Dis. 8(1), 98-105 (2004).
50. Joosten SA, Goeman JJ, Sutherland JS et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun. 13(1), 71-82 (2012).
51. Anderson ST, Kaforou M, Brent AJ et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N. Engl. J. Med. 370(18), 1712-1723 (2014).
52. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9(8), 839-845 (2008).
53. Lu L-F, Thai T-H, Calado DP et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30(1), 80-91 (2009).
54. Curtale G, Citarella F, Carissimi C et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115(2), 265-273 (2010).
55. Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl Acad. Sci. USA 106(44), 18704-18709 (2009).
56. Kleinsteuber K, Heesch K, Schattling S et al. Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4+ T cells and peripheral blood from tuberculosis patients. PLoS ONE 8(4), e61609 (2013).
57. Spinelli SV, Diaz A, D'Attilio L et al. Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response. Mol. Immunol. 53(3), 265-269 (2013).
58. Wang J, Yu M, Yu G et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 394(1), 184-188 (2010).
59. Sharbati J, Lewin A, Kutz-Lohroff B, Kamal E, Einspanier R, Sharbati S. Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis Infection. PLoS ONE 6(5), e20258 (2011).
60. Rahimian A, Soleimani M, Kaviani S et al. Bypassing the maturation arrest in myeloid cell line U937 by overexpression of microRNA-424. Hematology 16(5), 298-302 (2011).
61. Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-κBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103(33), 12481-12486 (2006).
62. Rosa A, Ballarino M, Sorrentino A et al. The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl Acad. Sci. USA 104(50), 19849-19854 (2007).
63. Forrest AR, Kanamori-Katayama M, Tomaru Y et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24(2), 460-466 (2010).
64. Rasmussen KD, Simmini S, Abreu-Goodger C et al. The miR-144/451 locus is required for erythroid homeostasis. J. Exp. Med. 207(7), 1351-1358 (2010).
65. Ishii M, Wen H, Corsa CAS et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114(15), 3244-3254 (2009).
66. Gamper CJ, Agoston AT, Nelson WG, Powell JD. Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J. Immunol. 183(4), 2267-2276 (2009).
67. Schoenborn JR, Dorschner M, Sekimata M et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing Ifng transcription. Nat. Immunol. 8(7), 732-742 (2007).
68. Das PM, Ramachandran K, VanWert J et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol. Cancer 5(1), 28 (2006).
69. Andraos C, Koorsen G, Knight JC, Bornman L. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum. Immunol. 72(3), 262-268 (2011).
70. Ramagopalan SV, Heger A, Berlanga AJ et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20(10), 1352-1360 (2010).
71. Kato S. The function of vitamin D receptor in vitamin D action. J. Biochem. (Tokyo) 127(5), 717-722 (2000).
72. Bornman L, Campbell SJ, Fielding K et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J. Infect. Dis. 190(9), 1631-1641 (2004).
73. Lombard Z, Dalton D-L, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and Vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum. Immunol. 67(8), 643-654 (2006).
74. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Narayanan PR. Regulatory region polymorphisms of vitamin D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south india. Int. J. Immunogenet. 35(3), 251-254 (2008).
75. Marik R, Fackler M, Gabrielson E et al. DNA methylationrelated vitamin D receptor insensitivity in breast cancer. Cancer Biol. Ther. 10(1), 44-53 (2010).
76. Strickland FM, Hewagama A, Lu Q et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J. Autoimmun. 38(2-3), J135-J143 (2012).
77. Janson PCJ, Linton LB, Ahlen Bergman E et al. Profiling of CD4+ T cells with epigenetic immune lineage analysis. J. Immunol. 186(1), 92-102 (2011).
78. Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375(9729), 1920-1937 (2010).
79. WHO. Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnosis (2009). www.stoptb.org
80. Lawn SD, Mwaba P, Bates M et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect. Dis. 13(4), 349-361 (2013).
81. Fallahi-Sichani M, El-Kebir M, Marino S, Kirschner DE, Linderman JJ. Multiscale computational modeling reveals a critical role for TNF-receptor 1 dynamics in tgranuloma formation. J. Immunol. 186(6), 3472-3483 (2011).
82. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat. Biotechnol. 22(10), 1253-1259 (2004).